Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva with Docetaxel and Cisplatin/Carboplatin in Metastatic or Recurrent SCCHN
NCT01064479Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2010
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2010; status: completed.
02
Drugs
erlotinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01064479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064479.